Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lonn

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Antiatherosclerotic effects of ACE inhibitors: where are we now?E Lonn
International Journal of Clinical Practice. Supplement|November 22, 2001
Modifying the natural history of atherosclerosis: the SECURE trialE Lonn
Pharmacoepidemiology and Drug Safety|February 7, 2002
The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseasesE Lonn
The Canadian Journal of Cardiology|May 31, 2001
Use of carotid ultrasound to stratify riskE Lonn
European Heart Journal|October 31, 1998
Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trialsS Yusuf, E Lonn
The Canadian Journal of Cardiology|December 1, 1999
Echocardiographically guided pericardiocentesis - the gold standard for the management of pericardial effusion and cardiac tamponadeK Salem, A Mulji, E Lonn
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Summary of randomized trials of angiotensin converting enzyme inhibitorsS Yusuf, E Lonn, J Bosch, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1993
Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trialsS Yusuf, J Lessem, P Jha, et al.
Annals of Internal Medicine|December 1, 1995
The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial dataP Jha, M Flather, E Lonn, et al.
Annals of Internal Medicine|September 4, 1999
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidenceJ W Eikelboom, E Lonn, J Genest, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Antiatherosclerotic effects of ACE inhibitors: where are we now?E Lonn
International Journal of Clinical Practice. Supplement|November 22, 2001
Modifying the natural history of atherosclerosis: the SECURE trialE Lonn
Pharmacoepidemiology and Drug Safety|February 7, 2002
The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseasesE Lonn
The Canadian Journal of Cardiology|May 31, 2001
Use of carotid ultrasound to stratify riskE Lonn
European Heart Journal|October 31, 1998
Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trialsS Yusuf, E Lonn
The Canadian Journal of Cardiology|December 1, 1999
Echocardiographically guided pericardiocentesis - the gold standard for the management of pericardial effusion and cardiac tamponadeK Salem, A Mulji, E Lonn
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Summary of randomized trials of angiotensin converting enzyme inhibitorsS Yusuf, E Lonn, J Bosch, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1993
Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trialsS Yusuf, J Lessem, P Jha, et al.
Annals of Internal Medicine|December 1, 1995
The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial dataP Jha, M Flather, E Lonn, et al.
Annals of Internal Medicine|September 4, 1999
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidenceJ W Eikelboom, E Lonn, J Genest, et al.
Pageof 4